MIB-1 immunolabeling: A valuable marker in prediction of benign recurring meningiomas

Neuropathology

Volumn 27, Issue 5, 2007, Pages 407-412

  Vankalakunti, Mahesha ^a   Vasishta, Rakesh Kumar ^a   Radotra, Bishan Das ^a   Khosla, Virender Kumar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Meningioma; MIB 1; Proliferative potential; Recurrence

Indexed keywords

KI 67 ANTIGEN;

ANAPLASTIC CARCINOMA; ANTIBODY LABELING; ARTICLE; BENIGN TUMOR; CELL AGGREGATION; CELL PROLIFERATION; CONTROLLED STUDY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; MAJOR CLINICAL STUDY; MENINGIOMA; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR CELL; TUMOR RECURRENCE;

BIOLOGICAL MARKERS; BRAIN NEOPLASMS; HUMANS; KI-67 ANTIGEN; MENINGEAL NEOPLASMS; MENINGIOMA; MITOTIC INDEX; NEOPLASM INVASIVENESS; PROBABILITY; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 34648827907     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2007.00801.x     Document Type: Article

References (19)

1. Russell DS, Rubinstein LJ. Tumours of the meninges and related tissues. In : Pathology of Tumours of the Nervous System. London : Edward Arnold, 1989 449 507.
2. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ. Menigniomas. In : Kleihues P, Cavenee WK, eds. Pathology and Genetics. Tumors of the Nervous System: WHO Classification of Tumors, 1st edn. Lyon : IARC Press, 2000 176 184.
3. Abramovich CM, Prayson RA. Histopathologic Features and Ki-67 Labeling Indices in Recurrent and Nonrecurrent Meningiomas. Arch Pathol Lab Med 1999 123 : 793 800.
4. Marks SM, Whitnell HL, Lye RH. Recurrence of meningiomas after operation. Surg Neurol 1986 25 : 436 440.
5. Adegbite AB, Khan MI, Paine KWE, Tan KL. The recurrence of Intracranial meningioma after surgical Treatment. J Neurosurg 1983 58 : 51 56.
6. de la Monte SM, Flickinger J, Lingood RM. Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 1986 10 : 836 843.
7. Langford LA, Cooksley CS, DeMonte F. Comparison of KI-67 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 1996 27 : 350 354.
8. Demirtas E, Yilmaz F, Ovul I, Oner K. Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting. Acta Neurochir (Wien) 1996 138 : 1456 1463.
9. Ho DM, Hsu CY, Ting LT, Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 2002 94 : 1538 1547.
10. Ohta M, Iwaki T, Kitamoto T et al. KI-67 staining index and scoring of histologic features in meningioma. Cancer 1994 74 : 3176 3189.
11. Izycka-Swieszewska E, Rzepko R, Borowska-Lehman J et al. Recurrent meningiomas- the immunohistochemical analysis of angiogenesis and cellular proliferation. Folia Neuropathol 1999 37 : 179 184.
12. Karamitopoulou E, Perentes E, Tonlay M et al. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 1998 29 : 140 145.
13. Guillaud P, DuManoir S, Seigneurin D. Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumor cell lines (MCF-7). Anal Cell Pathol 1989 1 : 25 39.
14. Verheijen R, Kuijpers HJH, Van Driel R et al. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. IL-Localization in mitotic cells and association with chromosomes. J Cell Sci 1989 92 : 531 540.
15. Devaprasath A, Chacko G. Diagnostic Validity of the Ki-67 labeling index using the Mib-1 monoclonal aantibody in the grading of meningiomas. Neurol India 2003 51 : 336 340.
16. Lanzafame S, Torrisi A, Barbagallo G, Emmanuele C, Alberio N, Albanese V. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Pathol Res Pract 2000 196 : 483 488.
17. Sandberg DI, Edgar MA, Resch L, Rutka JT, Becker LE, Souweidane MM. MIB-1 staining index of pediatric meningiomas. Neurosurgery 2001 48 : 590 595 discussion 595-597.
18. Matsuno A, Fujimaki T, Sasaki T et al. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 1996 91 : 504 510.
19. Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M. Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol 2001 25 : 472 478.